Use of thrombopoietin receptor agonists in childhood immune thrombocytopenia

• Váldodahkkit: Angelica Maria Garzon (Dahkki), William Beau Mitchell (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2015-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Most children with immune thrombocytopenia (ITP) will have spontaneous remission regardless of therapy, while about 20% will go on to have chronic ITP. In those children with chronic ITP who need treatment, standard therapies for acute ITP may have adverse effects that complicate their long term use...